Canada markets open in 4 hours 51 minutes

Curis, Inc. (CRIS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
10.80+0.27 (+2.61%)
At close: 04:00PM EDT
10.90 +0.10 (+0.97%)
After hours: 04:56PM EDT
Full screen
Loading interactive chart...
  • PR Newswire

    Curis Announces Additional Data from TakeAim Leukemia Study

    Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced updated data from the ongoing TakeAim Leukemia study (CA-4948-102) in relapsed/refractory (R/R) AML to be presented at the ASCO and EHA conferences.

  • PR Newswire

    Curis to Present Updated Data from the TakeAim Leukemia Study

    Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will present updated data from the TakeAim Leukemia study Tuesday, May 14, 2024, at 4:00 p.m. ET. Management will host a conference call on the same day at 4:30 p.m. ET.

  • Insider Monkey

    Curis, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call Transcript

    Curis, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call Transcript May 7, 2024 Curis, Inc. misses on earnings expectations. Reported EPS is $-2.0534 EPS, expectations were $-1.94. CRIS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and […]